HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-AUG-18 5QIL TITLE TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4- TITLE 2 [3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2-YL]PYRIDIN-2- TITLE 3 YL}ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 200-503; COMPND 5 SYNONYM: TGFR-1,ACTIVIN A RECEPTOR TYPE II-LIKE PROTEIN KINASE OF COMPND 6 53KD,ACTIVIN RECEPTOR-LIKE KINASE 5,ALK5,SERINE/THREONINE-PROTEIN COMPND 7 KINASE RECEPTOR R4,SKR4,TGF-BETA TYPE I RECEPTOR,TRANSFORMING GROWTH COMPND 8 FACTOR-BETA RECEPTOR TYPE I,TBETAR-I; COMPND 9 EC: 2.7.11.30; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGFBR1, ALK5, SKR4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS ALK5, SB431542, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 4 06-MAR-24 5QIL 1 REMARK REVDAT 3 12-MAY-21 5QIL 1 REMARK REVDAT 2 26-DEC-18 5QIL 1 JRNL REVDAT 1 31-OCT-18 5QIL 0 JRNL AUTH Y.ZHANG,Y.ZHAO,A.J.TEBBEN,S.SHERIFF,M.RUZANOV,M.P.FERESHTEH, JRNL AUTH 2 Y.FAN,J.LIPPY,J.SWANSON,C.P.HO,B.S.WAUTLET,A.ROSE,K.PARRISH, JRNL AUTH 3 Z.YANG,A.F.DONNELL,L.ZHANG,B.E.FINK,G.D.VITE, JRNL AUTH 4 K.AUGUSTINE-RAUCH,J.FARGNOLI,R.M.BORZILLERI JRNL TITL DISCOVERY OF 4-AZAINDOLE INHIBITORS OF TGF BETA RI AS JRNL TITL 2 IMMUNO-ONCOLOGY AGENTS. JRNL REF ACS MED CHEM LETT V. 9 1117 2018 JRNL REFN ISSN 1948-5875 JRNL PMID 30429955 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00357 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20531 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT : 987 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2934 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1807 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2794 REMARK 3 BIN R VALUE (WORKING SET) : 0.1773 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2408 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.86620 REMARK 3 B22 (A**2) : -13.53260 REMARK 3 B33 (A**2) : 8.66640 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.188 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.179 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.150 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.170 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.147 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2514 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3409 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 891 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 55 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 408 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2514 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 320 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3072 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5QIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-AUG-18. REMARK 100 THE DEPOSITION ID IS D_1001401994. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20725 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 41.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09200 REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36500 REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3TZM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23%(W/V) PEG3350, 3%(V/V) GLCYEROL, PH REMARK 280 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.54000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.49000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.54000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.49000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 500 REMARK 465 ILE A 501 REMARK 465 LYS A 502 REMARK 465 MET A 503 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 198 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 213 CD CE NZ REMARK 470 HIS A 371 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 456 CG OD1 ND2 REMARK 470 GLN A 497 CG CD OE1 NE2 REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 GLU A 499 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 216 -51.16 -124.67 REMARK 500 GLN A 324 71.12 -105.07 REMARK 500 ARG A 332 -4.23 75.30 REMARK 500 ASP A 333 38.32 -148.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue J2V A 601 DBREF 5QIL A 200 503 UNP P36897 TGFR1_HUMAN 200 503 SEQADV 5QIL GLY A 197 UNP P36897 EXPRESSION TAG SEQADV 5QIL HIS A 198 UNP P36897 EXPRESSION TAG SEQADV 5QIL MET A 199 UNP P36897 EXPRESSION TAG SEQADV 5QIL ASP A 204 UNP P36897 THR 204 ENGINEERED MUTATION SEQRES 1 A 307 GLY HIS MET THR ILE ALA ARG ASP ILE VAL LEU GLN GLU SEQRES 2 A 307 SER ILE GLY LYS GLY ARG PHE GLY GLU VAL TRP ARG GLY SEQRES 3 A 307 LYS TRP ARG GLY GLU GLU VAL ALA VAL LYS ILE PHE SER SEQRES 4 A 307 SER ARG GLU GLU ARG SER TRP PHE ARG GLU ALA GLU ILE SEQRES 5 A 307 TYR GLN THR VAL MET LEU ARG HIS GLU ASN ILE LEU GLY SEQRES 6 A 307 PHE ILE ALA ALA ASP ASN LYS ASP ASN GLY THR TRP THR SEQRES 7 A 307 GLN LEU TRP LEU VAL SER ASP TYR HIS GLU HIS GLY SER SEQRES 8 A 307 LEU PHE ASP TYR LEU ASN ARG TYR THR VAL THR VAL GLU SEQRES 9 A 307 GLY MET ILE LYS LEU ALA LEU SER THR ALA SER GLY LEU SEQRES 10 A 307 ALA HIS LEU HIS MET GLU ILE VAL GLY THR GLN GLY LYS SEQRES 11 A 307 PRO ALA ILE ALA HIS ARG ASP LEU LYS SER LYS ASN ILE SEQRES 12 A 307 LEU VAL LYS LYS ASN GLY THR CYS CYS ILE ALA ASP LEU SEQRES 13 A 307 GLY LEU ALA VAL ARG HIS ASP SER ALA THR ASP THR ILE SEQRES 14 A 307 ASP ILE ALA PRO ASN HIS ARG VAL GLY THR LYS ARG TYR SEQRES 15 A 307 MET ALA PRO GLU VAL LEU ASP ASP SER ILE ASN MET LYS SEQRES 16 A 307 HIS PHE GLU SER PHE LYS ARG ALA ASP ILE TYR ALA MET SEQRES 17 A 307 GLY LEU VAL PHE TRP GLU ILE ALA ARG ARG CYS SER ILE SEQRES 18 A 307 GLY GLY ILE HIS GLU ASP TYR GLN LEU PRO TYR TYR ASP SEQRES 19 A 307 LEU VAL PRO SER ASP PRO SER VAL GLU GLU MET ARG LYS SEQRES 20 A 307 VAL VAL CYS GLU GLN LYS LEU ARG PRO ASN ILE PRO ASN SEQRES 21 A 307 ARG TRP GLN SER CYS GLU ALA LEU ARG VAL MET ALA LYS SEQRES 22 A 307 ILE MET ARG GLU CYS TRP TYR ALA ASN GLY ALA ALA ARG SEQRES 23 A 307 LEU THR ALA LEU ARG ILE LYS LYS THR LEU SER GLN LEU SEQRES 24 A 307 SER GLN GLN GLU GLY ILE LYS MET HET J2V A 601 44 HETNAM J2V N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2- HETNAM 2 J2V B]PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE FORMUL 2 J2V C20 H17 N5 O2 FORMUL 3 HOH *156(H2 O) HELIX 1 AA1 ILE A 201 ARG A 203 5 3 HELIX 2 AA2 GLU A 238 GLN A 250 1 13 HELIX 3 AA3 SER A 287 TYR A 295 1 9 HELIX 4 AA4 THR A 298 MET A 318 1 21 HELIX 5 AA5 THR A 375 MET A 379 5 5 HELIX 6 AA6 ALA A 380 ASP A 385 1 6 HELIX 7 AA7 PHE A 393 ARG A 414 1 22 HELIX 8 AA8 SER A 437 CYS A 446 1 10 HELIX 9 AA9 PRO A 455 SER A 460 5 6 HELIX 10 AB1 CYS A 461 TRP A 475 1 15 HELIX 11 AB2 ASN A 478 ARG A 482 5 5 HELIX 12 AB3 THR A 484 GLU A 499 1 16 SHEET 1 AA1 5 ILE A 205 LYS A 213 0 SHEET 2 AA1 5 GLU A 218 TRP A 224 -1 O ARG A 221 N GLN A 208 SHEET 3 AA1 5 GLU A 227 SER A 235 -1 O GLU A 227 N TRP A 224 SHEET 4 AA1 5 THR A 274 ASP A 281 -1 O LEU A 278 N LYS A 232 SHEET 5 AA1 5 PHE A 262 ASP A 269 -1 N ILE A 263 O VAL A 279 SHEET 1 AA2 3 ALA A 328 ALA A 330 0 SHEET 2 AA2 3 VAL A 356 ASP A 359 -1 O HIS A 358 N ALA A 328 SHEET 3 AA2 3 THR A 364 ILE A 365 -1 O THR A 364 N ASP A 359 SHEET 1 AA3 2 ILE A 339 VAL A 341 0 SHEET 2 AA3 2 CYS A 347 ILE A 349 -1 O CYS A 348 N LEU A 340 SITE 1 AC1 16 ILE A 211 VAL A 219 ALA A 230 LYS A 232 SITE 2 AC1 16 LEU A 260 SER A 280 ASP A 281 TYR A 282 SITE 3 AC1 16 HIS A 283 GLU A 284 GLY A 286 THR A 323 SITE 4 AC1 16 LEU A 340 ASP A 351 HOH A 704 HOH A 714 CRYST1 41.600 76.980 89.080 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012990 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011226 0.00000